1 January 2020 in Journal of Cardiovascular Imaging
Bragança B, et al. J Cardiovasc Imaging. 2019 Sep;28:e25. https://doi.org/10.4250/jcvi.2019.0094
20 August 2021 in Frontiers in Pharmacology
ACAlexandrina Campos-Martins
Alexandrina Campos-Martins
Heart failure with preserved ejection fraction (HFpEF) roughly represents half of the cardiac failure events in developed countries. The proposed ‘systemic microvascular paradigm’ has been used to explain HFpHF presentation heterogeneity. The lack of effective treatments with few evidence-based therapeutic recommendations makes HFpEF one of the greatest unmet clinical necessities worldwide. The endogenous levels of the purine nucleoside, adenosine, increase significantly following cardiovascular events. Adenosine exerts cardioprotective, neuromodulatory, and immunosuppressive effects by activating plasma membrane-bound P1 receptors that are widely expressed in the cardiovascular system. Its proven benefits have been demonstrated in preclinical animal tests. Here, we provide a comprehensive and up-to-date critical review about the main therapeutic advantages of tuning adenosine signalling pathways in HFpEF, without discounting their side effects and how these can be seized.
23 June 2025 in Netherlands Heart Journal
Background: Persistent congestion in heart failure (HF) carries a dismal prognosis. Bioimpedance analysis (BIA) non-invasively identifies extracellular water (ECW) redistribution associated with acute HF. However, its role in detecting subclinical congestion in HF outpatients still needs to be explored. Methods: Eighty-three adult outpatients with HFrEF were recruited for a single-center prospective study. Segmental multi-frequency BIA was used to assess body composition and the extracellular-to-total body water ratio (ECW/TBW), a marker of fluid redistribution. Subclinical congestion was defined as ECW/TBWz‑score > 2 without clinical signs of congestion. The primary outcome was a composite of all-cause death and worsening HF (WHF) events. Results: In this cohort, 57% of patients had subclinical congestion. Higher congestion grades were associated with age, female sex, and comorbidities. ECW/TBWz‑score correlated linearly with NT-proBNP levels and low muscular indexes were associated with congestion severity. During a median follow-up of 10 months, 27% of patients experienced the primary outcome, mostly WHF events. Both subclinical and clinical congestion were independently associated with an increased risk of the primary outcome, with hazard ratios (HR) of 9.4 (1.04–85.1; p = 0.046) and 17 (1.11–261; p = 0.042), respectively. NT-proBNP and ECW/TBWz‑score showed similar power in predicting the outcome. Conclusions: BIA detects subclinical congestion—a condition highly prevalent in outpatients with HFrEF. An increased ECW/TBW ratio correlates with established markers of congestion and is associated with adverse events in this population. These findings support the integration of BIA into routine HF care; however, further studies are needed to establish the clinical benefits of BIA-guided management and its impact on patient outcomes.
31 January 2023 in Arquivos Brasileiros de Cardiologia
1 January 2026 in International Journal of Heart Failure
Pereira Santos M, et al. Int J Heart Fail. 2026 Jul;8(3):256-262. https://doi.org/10.36628/ijhf.2026.0016